Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) is an important treatment for ovarian cancer. A certain portion of cisplatin exits the body via the perfusate at the end of HIPEC, so full-dose utilization cannot be achieved. Herein, we sought to explore how much cisplatin is actually ut...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wu-yun, Wu, Miao-fang, Wu, Dong-bing, Wang, Li-juan, Li, Hui, Lin, Zhong-qiu, Li, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796576/
https://www.ncbi.nlm.nih.gov/pubmed/33419462
http://dx.doi.org/10.1186/s13048-021-00764-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7796576/
https://www.ncbi.nlm.nih.gov/pubmed/33419462
http://dx.doi.org/10.1186/s13048-021-00764-6

Ejemplares similares